Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
1.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RpS12-mediated induction of the Xrp1<sup>short</sup> isoform links ribosomal protein mutations to cell competition.

Cell reportsĀ·2026
Same author

Microbial signals meet regulatory DNA: Gut microbiota control liver gene expression through cis-regulatory elements.

Molecular cellĀ·2026
Same author

An aerosolized dual-action autotaxin inhibitor-PPARĪ³ agonist for the treatment of pulmonary fibrosis.

Cell reports. MedicineĀ·2026
Same author

MicroRNA prognostic markers for immune checkpoint inhibitor success in urologic cancers.

ImmunotherapyĀ·2026
Same author

Assessing Genetic Risk for Physical Activity and Its Interaction with Diet in Predicting Activity Levels and Weight Loss in the iMPROVE Study.

GenesĀ·2026
Same author

Rapid Remodeling of the Human Gut Microbiome in Response to Short-Term Animal Product Restriction and Associations with Host Molecular Phenotypes.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)Ā·2026

Related Experiment Video

Updated: Mar 16, 2026

Studying TGF-&#946; Signaling and TGF-&#946;-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.7K

Smyd3-associated regulatory pathways in cancer.

Antonis Giakountis1, Panagiotis Moulos1, Michalis E Sarris1

  • 1Biomedical Sciences Research Center Alexander Fleming, 16672 Vari, Greece.

Seminars in Cancer Biology
|August 25, 2016
PubMed
Summary

SMYD3, a cancer-associated methyltransferase, amplifies oncogenes in the nucleus and potentiates Ras/ERK signaling in the cytoplasm. Its prognostic value in lung cancer is revealed when considering patient smoking history.

Keywords:
CancerEpigenetic mechanismsHistone methylationSmyd3

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.4K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

941

Related Experiment Videos

Last Updated: Mar 16, 2026

Studying TGF-&#946; Signaling and TGF-&#946;-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.7K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.4K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

941

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • SMYD3 (SET and MYND-domain containing 3) is a methyltransferase linked to poor prognosis in multiple cancers.
  • Its subcellular localization (nucleus vs. cytoplasm) dictates distinct oncogenic functions in different tumor types.

Purpose of the Study:

  • To elucidate the dual role of SMYD3 in cancer progression.
  • To investigate the prognostic significance of SMYD3 in lung cancer, considering clinical and lifestyle factors.

Main Methods:

  • Analysis of SMYD3 localization and interactions with RNA Pol II and H3K4me3 in liver and colon tumors.
  • Investigation of SMYD3's role in cytoplasmic Ras/ERK signaling via MAP3K2 methylation in lung and pancreatic cancer.
  • Clinico-pathological analysis of lung cancer patients, including stratification by smoking history.

Main Results:

  • Nuclear SMYD3 amplifies oncogenes and proliferation/metastasis genes in liver and colon cancer, correlating with poor prognosis.
  • Cytoplasmic SMYD3 potentiates Ras/ERK signaling in lung and pancreatic cancer by methylating MAP3K2.
  • SMYD3's prognostic value in lung cancer for overall survival is unmasked by stratifying patients based on smoking history.

Conclusions:

  • SMYD3 exhibits context-dependent oncogenic functions based on its subcellular localization.
  • Smoking history is a critical factor that can mask or reveal the prognostic significance of SMYD3 in lung cancer.
  • Targeting SMYD3 may offer therapeutic strategies, but its efficacy might be influenced by smoking status.